Different Doses of Colchicine on hsCRP

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.

Also called NCT06078904

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 200 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT06078904
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT06078904. Randomized; quadruple masking; primary purpose treatment. Start 2023-10-10 (actual); primary completion 2023-12-25 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Different Doses of Colchicine on hsCRP
Intervention (Drug)
Colchicine 0.5 MG
Intervention (Drug)
Colchicine 0.375 MG
Intervention (Drug)
Colchicine 0.25 MG
Intervention (Drug)
Placebo
Lead sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (class: other)

Record details

Record id
cardio:ct-nct06078904
Content hash
0ad1822f56fa7cb001af96e250e8df0592bca68088d63c60bac1b16ce0c748e9